Discover 1,900 paid clinical trials in Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Virginia provides numerous opportunities for both healthy volunteers and people with specific medical conditions to participate in paid medical research. Major research centers in Richmond, Virginia Beach, and Norfolk are actively seeking participants, offering access to innovative treatments and advanced care.
Filter
1
Filter results
Results: 1,900
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Saint John, Bath ME, Portland ME, Scarborough ME,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase 3, Recruiting
Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
for
Non-small Cell Lung Cancer Stage III
Location: Washington D.C. DC, Charlottesville VA, St Louis MO
Sponsor: Georgetown University
Sex: All
Age: 18+
Code: NCT06449313
Phase 2, Recruiting
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
for
Narcolepsy Type 2
Location: Middletown NJ, Norfolk VA, Bowie MD, Miami FL,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06952699
Phase 2, Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for
Pediatric Migraine
Location: East Greenwich RI, Cromwell CT, Commack NY, Stamford CT,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04649242
Phase 3, Recruiting
US National OCS Heart Perfusion (OHP) Registry
for
Heart Transplant
Location: Boston MA, New Haven CT, Valhalla NY, The Bronx NY,
Sponsor: TransMedics
Sex: All
Age: 0+
Code: NCT05915299
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
for
Mitral Valve Regurgitation
Location: Boston MA, Hartford CT, New Haven CT, Roslyn NY,
Sponsor: Medtronic Cardiovascular
Sex: All
Age: 18+
Code: NCT03242642
Recruiting
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
for
Advanced Lung Non-Small Cell Carcinoma,
Location: Boston MA, Wynnewood PA, Bryn Mawr PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03191149
Phase 2, Recruiting
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
for
Advanced Solid Tumors
Location: Boston MA, Fairfax VA, Lake Mary FL, Denver CO,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06907043
Phase 1, Phase 2, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: PMV Pharmaceuticals, Inc
Sex: All
Age: 12+
Code: NCT04585750
Phase 1, Phase 2, Recruiting
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
for
Viral Lung Infection and Acute Respiratory Failure
Location: Levis, Quebec, New York NY, Montreal, Annapolis MD,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05624450
Phase 3, Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
for
Intracranial Meningioma, Recurrent Meningioma,
Location: Boston MA, Hartford CT, New Haven CT,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT02523014
Phase 2, Recruiting
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy
for
NSCLC Stage IV
Location: Saint John, Richmond VA, Fairfax VA, Fort Lauderdale FL,
Sponsor: ImmunityBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06745908
Phase 3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Halifax, Saint John, New Bedford MA, Braintree MA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase 3, Recruiting
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
for
Castration-Resistant Prostate Carcinoma,
Location: Millville DE, Lewes DE, Rehoboth Beach DE,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT06470243
Phase 3, Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for
Acute Treatment of Migraine
Location: East Greenwich RI, Cromwell CT, Commack NY, Stamford CT,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04743141
Phase 3, Recruiting
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
for
Metastatic Renal Cell Carcinoma,
Location: Boston MA, Bay Shore NY, Commack NY, Greenlawn NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05327686
Phase 2, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Brewer ME, Gloucester MA, South Weymouth MA, Beverly MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase 2, Phase 3, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study